Yoshimasa Tokuchi
Iwamizawa, Japan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 32 publications
Three-year overall survival in unresectable hepatocellular carcinoma treated with atezolizumab plus bevacizumab.
Journal: Hepatology international
Published: April 30, 2025
Serum FGF21 as a predictor of response to atezolizumab and bevacizumab in HCC.
Journal: JHEP reports : innovation in hepatology
Published: August 04, 2024
Successful Indirect Clipping for the Bleeding Source of Colonic Diverticular Hemorrhage Using a Reopenable Clip (Regrasping Technique).
Journal: ACG case reports journal
Published: June 20, 2024
Coexistence of muscle atrophy and high subcutaneous adipose tissue radiodensity predicts poor prognosis in hepatocellular carcinoma.
Journal: Frontiers in nutrition
Published: August 04, 2023
Potential Correlation between Changes in Serum FGF21 Levels and Lenvatinib-Induced Appetite Loss in Patients with Unresectable Hepatocellular Carcinoma.
Journal: Cancers
Published: May 21, 2023
Recent prevalence and characteristics of patients with hepatitis delta virus in Hokkaido, Japan.
Journal: Hepatology research : the official journal of the Japan Society of Hepatology
Published: April 20, 2023
Neutrophil gelatinase-associated lipocalin predicts the efficacy of tolvaptan for ascites in patients with liver cirrhosis.
Journal: Journal of gastroenterology
Published: January 31, 2023
Hepatitis C virus eradication by direct-acting antivirals causes a simultaneous increase in the prevalence of fatty liver and hyper low-density lipoprotein cholesterolemia without an increase in body weight.
Journal: Hepatology research : the official journal of the Japan Society of Hepatology
Published: December 15, 2022
Changes in Serum Growth Factors during Resistance to Atezolizumab Plus Bevacizumab Treatment in Patients with Unresectable Hepatocellular Carcinoma.
Journal: Cancers
Published: December 12, 2022
Serum Angiopoietin-2 Predicts the Occurrence and Recurrence of Hepatocellular Carcinoma after Direct-Acting Antiviral Therapy for Hepatitis C.
Journal: Viruses
Published: December 10, 2022
Prophylactic tenofovir alafenamide for hepatitis B virus reactivation and reactivation-related hepatitis.
Journal: Journal of medical virology
Published: September 16, 2022
Last Updated: 09/26/2026